BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16061569)

  • 21. Similar recombination-activating gene (RAG) mutations result in similar immunobiological effects but in different clinical phenotypes.
    IJspeert H; Driessen GJ; Moorhouse MJ; Hartwig NG; Wolska-Kusnierz B; Kalwak K; Pituch-Noworolska A; Kondratenko I; van Montfrans JM; Mejstrikova E; Lankester AC; Langerak AW; van Gent DC; Stubbs AP; van Dongen JJ; van der Burg M
    J Allergy Clin Immunol; 2014 Apr; 133(4):1124-33. PubMed ID: 24418478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Highly restricted human T cell repertoire in peripheral blood and tissue-infiltrating lymphocytes in Omenn's syndrome.
    Rieux-Laucat F; Bahadoran P; Brousse N; Selz F; Fischer A; Le Deist F; De Villartay JP
    J Clin Invest; 1998 Jul; 102(2):312-21. PubMed ID: 9664072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A variant of RAG1 gene identified in severe combined immunodeficiency: a case report.
    Zhang X; Kang X; Yang M; Cai Z; Song Y; Zhou X; Cao J; Wang C; Huang K; Peng Y; He J; Xiao Z
    BMC Pediatr; 2023 Feb; 23(1):56. PubMed ID: 36732712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical characteristics of human recombination activating gene 1 mutations in 8 immunodeficiency patients with diverse phenotypes].
    Yu G; Wang WJ; Liu DR; Tao ZF; Hui XY; Hou J; Sun JQ; Wang XC
    Zhonghua Er Ke Za Zhi; 2018 Mar; 56(3):186-191. PubMed ID: 29518828
    [No Abstract]   [Full Text] [Related]  

  • 25. From Severe Combined Immunodeficiency to Omenn syndrome after hematopoietic stem cell transplantation in a RAG1 deficient family.
    Martinez-Martinez L; Vazquez-Ortiz M; Gonzalez-Santesteban C; Martin-Nalda A; Vicente A; Plaza AM; Badell I; Alsina L; de la Calle-Martin O
    Pediatr Allergy Immunol; 2012 Nov; 23(7):660-6. PubMed ID: 22882342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modeling altered T-cell development with induced pluripotent stem cells from patients with RAG1-dependent immune deficiencies.
    Brauer PM; Pessach IM; Clarke E; Rowe JH; Ott de Bruin L; Lee YN; Dominguez-Brauer C; Comeau AM; Awong G; Felgentreff K; Zhang YH; Bredemeyer A; Al-Herz W; Du L; Ververs F; Kennedy M; Giliani S; Keller G; Sleckman BP; Schatz DG; Bushman FD; Notarangelo LD; Zúñiga-Pflücker JC
    Blood; 2016 Aug; 128(6):783-93. PubMed ID: 27301863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Three faces of recombination activating gene 1 (RAG1) mutations.
    Patiroglu T; Akar HH; Van Der Burg M
    Acta Microbiol Immunol Hung; 2015 Dec; 62(4):393-401. PubMed ID: 26689875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations in Recombination Activating Gene 1 and 2 in patients with severe combined immunodeficiency disorders in Egypt.
    Meshaal S; El Hawary R; Elsharkawy M; Mousa RK; Farid RJ; Abd Elaziz D; Alkady R; Galal N; Massaad MJ; Boutros J; Elmarsafy A
    Clin Immunol; 2015 Jun; 158(2):167-73. PubMed ID: 25869295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of immune function and analysis of RAG gene mutations in Omenn syndrome and related disorders.
    Wada T; Takei K; Kudo M; Shimura S; Kasahara Y; Koizumi S; Kawa-Ha K; Ishida Y; Imashuku S; Seki H; Yachie A
    Clin Exp Immunol; 2000 Jan; 119(1):148-55. PubMed ID: 10606976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A remarkable depletion of both naïve CD4+ and CD8+ with high proportion of memory T cells in an IPEX infant with a FOXP3 mutation in the forkhead domain.
    Costa-Carvalho BT; de Moraes-Pinto MI; de Almeida LC; de Seixas Alves MT; Maia RP; de Souza RL; Barreto M; Lourenço L; Vicente AM; Coutinho A; Carneiro-Sampaio M
    Scand J Immunol; 2008 Jul; 68(1):85-91. PubMed ID: 18489537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunological assessment of a patient with Omenn syndrome resulting from compound heterozygous mutations in the RAG1 gene.
    Mou W; Yang Z; Wang X; Hei M; Wang Y; Gui J
    Immunogenetics; 2023 Aug; 75(4):385-393. PubMed ID: 37269334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Omenn syndrome].
    Yachie A
    Ryoikibetsu Shokogun Shirizu; 2000; (32):23-6. PubMed ID: 11212702
    [No Abstract]   [Full Text] [Related]  

  • 33. Three-dimensional clustering of human RAG2 gene mutations in severe combined immune deficiency.
    Corneo B; Moshous D; Callebaut I; de Chasseval R; Fischer A; de Villartay JP
    J Biol Chem; 2000 Apr; 275(17):12672-5. PubMed ID: 10777560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The roles of the RAG1 and RAG2 "non-core" regions in V(D)J recombination and lymphocyte development.
    Jones JM; Simkus C
    Arch Immunol Ther Exp (Warsz); 2009; 57(2):105-16. PubMed ID: 19333736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An immunodeficiency disease with RAG mutations and granulomas.
    Schuetz C; Huck K; Gudowius S; Megahed M; Feyen O; Hubner B; Schneider DT; Manfras B; Pannicke U; Willemze R; Knüchel R; Göbel U; Schulz A; Borkhardt A; Friedrich W; Schwarz K; Niehues T
    N Engl J Med; 2008 May; 358(19):2030-8. PubMed ID: 18463379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A newly found homozygous mutation in recombination activating gene 1 in a patient with leaky severe combined immunodeficiency disorder.
    Salari F; Zaremehrjardi F; Arshi S; Bemanian MH; Fallahpour M; Shokri S; Seif F; Movahedi M; Nabavi M
    Mol Biol Rep; 2019 Dec; 46(6):6571-6575. PubMed ID: 31520268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutations in the tyrosine phosphatase CD45 gene in a child with severe combined immunodeficiency disease.
    Kung C; Pingel JT; Heikinheimo M; Klemola T; Varkila K; Yoo LI; Vuopala K; Poyhonen M; Uhari M; Rogers M; Speck SH; Chatila T; Thomas ML
    Nat Med; 2000 Mar; 6(3):343-5. PubMed ID: 10700239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular pathology of severe combined immunodeficiency in mice, horses, and dogs.
    Perryman LE
    Vet Pathol; 2004 Mar; 41(2):95-100. PubMed ID: 15017021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RAG-dependent primary immunodeficiencies.
    Sobacchi C; Marrella V; Rucci F; Vezzoni P; Villa A
    Hum Mutat; 2006 Dec; 27(12):1174-84. PubMed ID: 16960852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe combined immunodeficiency caused by deficiency in either the delta or the epsilon subunit of CD3.
    de Saint Basile G; Geissmann F; Flori E; Uring-Lambert B; Soudais C; Cavazzana-Calvo M; Durandy A; Jabado N; Fischer A; Le Deist F
    J Clin Invest; 2004 Nov; 114(10):1512-7. PubMed ID: 15546002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.